Evolent Health, Inc. financial data

Symbol
EVH on NYSE
Location
800 North Glebe Rd, Suite 500, Arlington, VA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 103 % -2.51%
Debt-to-equity 127 % +5.56%
Return On Assets -2.8 % +25.1%
Operating Margin -3.63 % -1448%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 117M shares +1.4%
Entity Public Float 3.4B USD +36%
Common Stock, Value, Issued 1.17M USD +1.57%
Weighted Average Number of Shares Outstanding, Basic 115M shares +2.3%
Weighted Average Number of Shares Outstanding, Diluted 115M shares +2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.96B USD +45.3%
Revenue from Contract with Customer, Excluding Assessed Tax 2.46B USD +37.6%
Cost of Revenue 2.07B USD +53.6%
Research and Development Expense 3.8M USD -9.52%
Costs and Expenses 2.51B USD +36.1%
Operating Income (Loss) -43.2M USD +16.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.2M USD +47%
Income Tax Expense (Benefit) -14.9M USD +79.7%
Net Income (Loss) Attributable to Parent -72.2M USD +20.6%
Earnings Per Share, Basic -0.91 USD/shares +10.8%
Earnings Per Share, Diluted -0.91 USD/shares +10.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 96.6M USD -47.7%
Accounts Receivable, after Allowance for Credit Loss, Current 408M USD +3.47%
Assets, Current 544M USD -14.8%
Property, Plant and Equipment, Net 73.9M USD -7.46%
Operating Lease, Right-of-Use Asset 9.24M USD -46.9%
Intangible Assets, Net (Excluding Goodwill) 697M USD -10.4%
Goodwill 1.14B USD +1.77%
Assets 2.5B USD -6.29%
Accounts Payable, Current 50.1M USD -3.26%
Employee-related Liabilities, Current 31.6M USD -36.9%
Accrued Liabilities, Current 120M USD -37.9%
Contract with Customer, Liability, Current 2.62M USD -54.5%
Liabilities, Current 524M USD -14.9%
Contract with Customer, Liability, Noncurrent 293K USD -80.6%
Deferred Income Tax Liabilities, Net 11.9M USD -55.8%
Operating Lease, Liability, Noncurrent 29.3M USD -26.1%
Other Liabilities, Noncurrent 3.25M USD -18.4%
Liabilities 1.28B USD -8.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.37M USD -8.06%
Retained Earnings (Accumulated Deficit) -758M USD -10.5%
Stockholders' Equity Attributable to Parent 1.04B USD -5.24%
Liabilities and Equity 2.5B USD -6.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.91M USD
Net Cash Provided by (Used in) Financing Activities 14.9M USD -96.1%
Net Cash Provided by (Used in) Investing Activities -9.73M USD +97.5%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 117M shares +1.53%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 128M USD -43.1%
Deferred Tax Assets, Valuation Allowance 32M USD -54.8%
Deferred Tax Assets, Gross 199M USD +6.06%
Operating Lease, Liability 35.5M USD -32.5%
Depreciation 30.5M USD -9.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104M USD +7.2%
Lessee, Operating Lease, Liability, to be Paid 43.2M USD -32.4%
Property, Plant and Equipment, Gross 247M USD -3.05%
Operating Lease, Liability, Current 6.22M USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.57M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.34M USD -33.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.67M USD -32.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.96M USD -13.4%
Deferred Tax Assets, Operating Loss Carryforwards 123M USD -6.22%
Unrecognized Tax Benefits 2.8M USD +75%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.81M USD -22.8%
Operating Lease, Payments 3.53M USD -7.89%
Additional Paid in Capital 1.82B USD +0.83%
Amortization of Intangible Assets 88.3M USD +10.7%
Depreciation, Depletion and Amortization 29.5M USD +0.78%
Deferred Tax Assets, Net of Valuation Allowance 167M USD +43%
Share-based Payment Arrangement, Expense 56.5M USD +26.8%
Interest Expense 47.3M USD +80.4%